<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Wai, R.T.</title>
    <link>http://repub.eur.nl/res/aut/6259/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Mastectomy by inverted drip incision and immediate reconstruction: data from 510 cases (Article)</title>
      <link>http://repub.eur.nl/res/pub/10131/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Immediate reconstruction of the breast can be performed in
      selected cases after mastectomy for breast cancer or after prophylactic
      mastectomy in patients with a high risk of developing breast cancer.
      Despite the frequency with which these procedures are performed, data from
      large series of subpectoral implantation of silicone prostheses in
      combination with a skin-saving approach are lacking. METHODS: In this
      retrospective study, data on complications and late surgical interventions
      in 356 patients who underwent 510 mastectomies with an inverted drip
      incision and immediate reconstruction (MIDIIR) were analyzed to determine
      potential prognostic factors of early complications. RESULTS: In 82% of
      the MIDIIRs, the postoperative course was uneventful. In 18%, the
      complications were infection (32 cases), necrosis of the skin flap (29
      cases), bleeding (31 cases), and protrusion of the prosthesis (20 cases),
      resulting in surgery in 9, 12, 15, and 20 cases, respectively. At the end
      of the follow-up period, 30 (6%) prostheses were definitively removed.
      Age, size of the prostheses, radiotherapy, previous lumpectomy, and
      indication for mastectomy were not significant factors for the prognosis
      of early complications. CONCLUSIONS: With the right technique and
      indications, MIDIIR is a very safe procedure and should be one of the
      surgical treatments that can be offered in the overall management of
      patients with, or at high risk for, breast cancer.</description>
    </item>
  </channel>
</rss>